Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DL-Carnitine HCl | Login | DL-Carnitine HCl | ||||||||||||||||
|
||||||||||||||||||
| Irisflorentin | Login | Irisflorentin | ||||||||||||||||
|
||||||||||||||||||
| DL-Menthol | Login | DL-Menthol | ||||||||||||||||
|
||||||||||||||||||
| Indacaterol Maleate | Login | Indacaterol Maleate | ||||||||||||||||
|
||||||||||||||||||
| Indacaterol Maleate | Login | Indacaterol Maleate | ||||||||||||||||
|
||||||||||||||||||
| Allocryptopine | Login | Allocryptopine | ||||||||||||||||
|
||||||||||||||||||
| Tetracycline HCl | Login | Tetracycline HCl | ||||||||||||||||
|
||||||||||||||||||
| DL-Carnitine HCl | Login | DL-Carnitine HCl | ||||||||||||||||
|
||||||||||||||||||
| L-Menthol | Login | L-Menthol | ||||||||||||||||
|
||||||||||||||||||
| Menthol | Login | Menthol | ||||||||||||||||
|
||||||||||||||||||
| Matrine | Login | Matrine | ||||||||||||||||
|
||||||||||||||||||
| Rolinsatamab Biosimilar(Anti-PRLR / Prolactin Receptor Reference Antibody) | Login | Rolinsatamab Biosimilar(Anti-PRLR / Prolactin Receptor Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| BAY-1158061 Biosimilar(Anti-PRLR / Prolactin Receptor Reference Antibody) | Login | BAY-1158061 Biosimilar(Anti-PRLR / Prolactin Receptor Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| Indatuximab Biosimilar (Anti-Syndecan-1 / CD138 Reference Antibody) | Login | Indatuximab Biosimilar (Anti-Syndecan-1 / CD138 Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| Indatuximab Biosimilar (Anti-Syndecan-1 / CD138 Reference Antibody) | Login | Indatuximab Biosimilar (Anti-Syndecan-1 / CD138 Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| Indatuximab Biosimilar (Anti-Syndecan-1 / CD138 Reference Antibody) | Login | Indatuximab Biosimilar (Anti-Syndecan-1 / CD138 Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| Amgen patent anti-beta amyloid Biosimilar(Anti-Amyloid Beta Reference Antibody ) | Login | Amgen patent anti-beta amyloid Biosimilar(Anti-Amyloid Beta Reference Antibody ) | ||||||||||||||||
|
||||||||||||||||||
| Academia Sinica patent anti-Clathrin Heavy Chain Biosimilar(Anti-Clathrin Heavy Chain / CHC Reference Antibody) | Login | Academia Sinica patent anti-Clathrin Heavy Chain Biosimilar(Anti-Clathrin Heavy Chain / CHC Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| HKT288 Biosimilar(Anti-CDH6 / K-Cadherin Reference Antibody) | Login | HKT288 Biosimilar(Anti-CDH6 / K-Cadherin Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| DS-6000A Biosimilar(Anti-CDH6 / K-Cadherin Reference Antibody) | Login | DS-6000A Biosimilar(Anti-CDH6 / K-Cadherin Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| PF-03732010 Biosimilar(Anti-CDH3 / P-cadherin Reference Antibody) | Login | PF-03732010 Biosimilar(Anti-CDH3 / P-cadherin Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| PTA001_A4 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody) | Login | PTA001_A4 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| 10C12 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody) | Login | 10C12 Biosimilar(Anti-CDH17 / Cadherin-17 Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| RG-6125 Biosimilar(Anti-CDH11 / Cadherin-11 Reference Antibody) | Login | RG-6125 Biosimilar(Anti-CDH11 / Cadherin-11 Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| Stem Centrx patent anti-Cadherin-1 Biosimilar(Anti-CDH1 / E-cadherin / CD324 Reference Antibody) | Login | Stem Centrx patent anti-Cadherin-1 Biosimilar(Anti-CDH1 / E-cadherin / CD324 Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||


